Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research - PowerPoint PPT Presentation

Loading...

PPT – Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research PowerPoint presentation | free to download - id: 87e39c-MjQwM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

Description:

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms. – PowerPoint PPT presentation

Number of Views:33

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research


1
Global Biological Drugs Market is Estimated to
Reach 394 Billion by 2024, Says Variant Market
Research
  • Geetanjali Raut
  • SEO Executive
  • Variant Market Research

2
Global Biological Drugs Market Global
Biological Drugs Market is estimated to reach
394 billion by 2024 growing at a CAGR of 10.3
from 2016 to 2024. Biological drugs are complex
molecules manufactured by using living plant or
animal cells or micro-organisms. They include a
wide range of products derived from animals,
humans or microorganisms by using biotechnology.
Unlike other drugs, biologic products must remain
constant by quality and purity throughout the
process as they are highly sensitive to very
minute changes during the process. Hence, it is
very essential for the biological drugs to be
manufactured in very controlled environment to
ensure predictable outcomes. Moreover, biological
drugs have aided in altering the treatment of
many serious and chronic illnesses to a great
extent. They are one of the most advanced
therapies available and have the ability to treat
cancer, ulcerative colitis, rheumatoid arthritis,
and other autoimmune diseases. Browse Complete
Report _at_ https//www.variantmarketresearch.com/re
port-categories/pharmaceuticals/biological-drugs-m
arket
3
Global Biological Drugs Market Size and Forecast,
2015 2024.
4
Biological Drugs Market The global
biological drugs market is categorized into
product type and geography. By product type, the
market is segmented into therapeutic protein
(Enbrel, Lantus, Neulasta, Avones, Novolog,
Rebif, Humalog, Aranesp, Epogen, Levemir,
Victoza, Betaseron, Neupogen, Eylea And Others),
monoclonal antibody (Humira, Remicade, Rituxan,
Avastin, Herceptin, Lucentis, And Others) and
vaccine (Prevnar 13, Gardasil, Fluzone, Varivax,
Cervarix, And Others).Get sample report _at_
https//www.variantmarketresearch.com/report-categ
ories/pharmaceuticals/biological-drugs-market/samp
le-request
5
Global Biological Drugs market share by region,
2024
6
Top Manufacturers
Baxter International Inc. Bristol-Myers Squibb
Company, Merck Co., Inc., Amgen Inc.,  Biogen
Inc.,  GlaxoSmithKline Plc, Novartis AG, Eli
Lilly and Co.,  Pfizer Inc., Abbott Laboratories,
7
  • The key takeaways from the report
  • Comprehensive analysis of market dynamics
    including factors and opportunities will be
    provided in the report
  • An exhaustive regional analysis of Global
    Biological Drugs Market from 2015 to 2024 has
    been included in the report
  • The report will include the qualitative and
    quantitative analysis with market estimation over
    2015-2024 and compound annual growth rate (CAGR)
    between 2016 and 2024
  • Profile of the key players in the Global
    Biological Drugs Market will be provided, which
    include key financials, product services, new
    developments and business strategies
  • The report will provide a detailed analysis of
    Global Biological Drugs Market with respect to
    major segments such as product type and geography

8
  • Scope of the Global Biological Drugs Market
  • Product Type Segments
  • Therapeutic Protein
  • Enbrel
  • Lantus
  • Neulasta
  • Avones
  • Novolog
  • Rebif
  • Humalog
  • Aranesp
  • Epogen
  • Levemir
  • Victoza
  • Betaseron
  • Neupogen

9
  • Scope of the Global Biological Drugs Market
  • Monoclonal Humira
  • Remicade
  • Rituxan
  • Avastin
  • Herceptin
  • Lucentis
  • Other Monoclonal Antibodies
  • Prevnar 13
  • Gardasil
  • Fluzone
  • Varivax
  • Cervarix
  • Other Vaccines

10
  • Scope of the Global Biological Drugs Market
  • Geography Segments
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others

11
Scope of the Global Biological Drugs Market
  • Asia-Pacific
  • India
  • China
  • Japan
  • South Korea
  • Others
  • RoW
  • South America
  • Middle East
  • Africa

12
Table Of Content
Chapter 1 Prefix 1.1 Market Scope 1.2
Report Description 1.3 Research Methodology
1.3.1 Primary Research 1.3.2
Secondary Research 1.3.3 In-house Data
Modeling Chapter 2 Executive Summary
13
Table Of Content
Chapter 3 Market Outline 3.1 Market
Inclination, Trend, Outlook and Viewpoint 3.2
Market Share Analysis Companys Competitive
Scenario 3.3 Value Chain Analysis 3.4
Market Dynamics 3.4.1 Drivers
3.4.1.1 Impact Analysis 3.4.2
Restraints 3.4.2.1 Impact
Analysis 3.4.3 Opportunities 3.5
Porters five forces analysis 3.5.1
Factors Impact Analysis ..
14
Table Of Content
Chapter 6 Company Profiles 6.1 Baxter
International Inc. 6.2 Bristol-Myers Squibb
Company 6.3 Merck Co., Inc. 6.4 Amgen
Inc. 6.5 Biogen Inc. 6.6 GlaxoSmithKline
Plc 6.7 Novartis AG 6.8 Eli Lilly and
Co. 6.9 Pfizer Inc. 6.10 Abbott
Laboratories
15
Contact Us
Variant Market Research LLP. Website
https//www.variantmarketresearch.com USA Office

649 Mission St,
5th Floor, San Francisco, CA 94105, United
States. Tel 1-415-680-2785 Fax
1-415-680-2786 Email help_at_variantmarketresearch.
com Follow Us LinkedIn Facebook Twitter
Google
16
Thank You
Follow Us.
About PowerShow.com